Objective: To investigate the expression of zinc finger transcription factors-Snail and E-cadherin in adriamycin-resistant human breast cancer MCF-7/ADM cells and non-resistant MCF-7 cells. Study Design: An experimental study. Place and Duration of Study: The Affiliated Cancer Hospital of Nanjing Medical University and Jiangsu Cancer Hospital, and Jiangsu Institute of Cancer Research, China, from April 2017 to March 2018. Methodology: Real-time quantitative PCR technology was used to detect the expression levels of Snail mRNA and E-cadherin mRNA in normal breast cells, adriamycin-resistant human breast cancer MCF-7/ADM cells and non-resistant MCF-7 cells. Western blot was used to detect the expression levels of proteins of Snail and E-cadherin in normal breast cells, adriamycin-resistant human breast cancer MCF-7/ADM cells and non-resistant MCF-7 cells. Results: The expression of Snail mRNA and protein in adriamycin-resistant human breast cancer MCF-7/ADM cells was significantly higher than that in normal breast cells (p<0.001) and non-resistant MCF-7 cells (p<0.001). The expression of E-cadherin mRNA and protein in adriamycin-resistant human breast cancer MCF-7/ADM cells was significantly lower than that in normal breast cells (p<0.001) and non-resistant MCF-7 cells (p<0.001). Conclusion: Adriamycin-resistant human breast cancer MCF-7/ADM cell strains had high expression of Snail and low expression of E-cadherin. This points out to a new research direction for the targeted therapy of drug-resistant breast cancer cells, and provides clinical guidance for breast cancer therapy and prognosis evaluation.
INTRODUCTION
Breast cancer is one of the most common malignant tumors among women, and it seriously threatens the lives of women. Chemotherapy is still an important treatment for breast cancer, but its overall therapeutic effect is still unsatisfactory, which is largely attributable to the development of drug resistance in tumor cells. 1, 2 Relevant data show that there is a broad range of doxorubicin resistance during chemotherapy, which is also the main reason for the failure of breast cancer doxorubicin treatment. 3 Therefore, it is particularly important to look for drugs and methods for overcoming drug resistance to doxorubicin in breast cancer. In addition, the primary cause of death in breast cancer patients is not the growth of preinvasive tumors, but the metastasis of tumors. 4 At present, it is considered that epithelial-mesenchymal transition (EMT) and detachment of primary tumor cells are the key steps for the completion of metastasis of tumor cells. 5 EMT is regulated by a variety of mechanisms. At present, many closely related transcription factors have been discovered. Among these, Snail is the most important type of transcription factor and belongs to the Snail superfamily of transcriptional repressors. 6 Many studies have shown that in epithelial tumors, the transcription factor Snail induces EMT by binding to Ebox in E-cadherin promoter region and down-regulating E-cadherin expression. Now, there is less research about Snail and E-cadherin in breast cancer.
The aim of this study was to determine the expression of the adriamycin-resistant human breast cancer MCF-7/ADM cell strain and the non-resistant MCF-7 cell strain on the zinc finger transcription factor Snail and E-cadherin, in order to provide a reference for overcoming the metastasis of breast cancer and doxorubicin resistance to breast cancer.
Ltd. Normal breast cells, adriamycin-resistant human breast cancer MCF-7/ADM cells and non-resistant MCF-7 cells were cultured in a medium containing 10% inactivated fetal calf serum, 100 g/mL penicillin and 0.1 mg/mL streptomycin, and was incubated in a constant temperature incubator at 37°C with 5% CO 2 ; and the cell growth was observed daily. After the degrees of fusion of cell strains reached 80-90%, passage was conducted. Then they were partially frozen.
RNA extraction and reverse transcription of cells: normal breast cells, adriamycin-resistant human breast cancer MCF-7/ADM cells and non-resistant MCF-7 cells were added to 6-well plates, and the merging of cells was 90-100%. The number of cells in each well is about 1×10 7 . After removing the supernatant and washing twice with PBS, 1mL TRIZOL reagent was added in per well. Shook well, and digested for 3-5 minutes. The specific operation was performed according to the kit instructions. At room temperature, in 12000r/min, it was centrifuged for half a minute, and then moved to the RNase-free collection tube. After that, 70 L RNA eluent was added, 10 L RNA sample was electrophoresed on 1% agar gel, and the integrity of extracted RNA was determined by a gel imaging system. Thereafter, 1 L RNA solution was taken and the nucleic acid content and purity were measured by using a NanoDrop 2000 ultramicro spectrophotometer. Reverse transcription was performed according to the reverse transcription reaction kit instructions. The RT reaction solution was prepared on ice with a total of 20 L: 1 L PrimeScriptTM RT Enzyme Mix I, 5x PrimeScriptTM Buffer, 1 L OligodT Primer, 1 L Random 6 mers, 1 g RNA. After diluted to 20 L with RNase Free dH 2 O, the reverse transcription reaction was performed on a PCR apparatus under the following conditions: 37°C, 15 min (reverse transcription reaction) and 85°C, 5 s (deactivate reactions of reverse transcriptase). After the reaction was completed, the reverse-transcribed cDNA was diluted 5-fold and stored at -20°C until use.
Real-time quantitative PCR was used to detect the expression levels of Snail mRNA and E-cadherin mRNA in normal breast cells, adriamycin-resistant human breast cancer MCF-7/ADM cells, and non-resistant MCF-7 cells. The specific method was as follows: constructed a 20 L Real Time-PCR reaction system, including 10 L Premix Ex TaqTM II (2×), 2 L cDNA, 0.4 L ROX Reference Dye (50×), 0.8 L upstream primer, 0.8 L downstream primer. The dH 2 O was diluted to 20 L. The RT reaction solution was added to the Real Time-PCR reaction system, with predegeneration at 95°C, for 15 seconds, denaturation at 94°C, for 60 seconds, annealing at 58°C, for 60 seconds, extension at 72°C, for 60 seconds, 40 cycles. GAPDH was used as the reference gene in this experiment. The GAPDH primer sequence was: upstream primer 5'-ACTAGGCGC TCACTGTTCTC-3', downstream primer 5'-CGACCAAA TCCGTTGACTCC-3'. The Snail primer sequence was: upstream primer 5'-CAACCCACTCAGATGTCAA-3', downstream primer 5'-CATAGTTAGTCACACCTCGT-3'. The E-cadherin primer sequence was: upstream primer 5'-ATTCTGATTCTGCTGCTCTTG-3', downstream primer 5'-AGTAGTCATAGTCCTGGTCTT-3'. 
DISCUSSION
In clinical practice, breast cancer is usually treated by surgery, chemotherapy, radiotherapy, endocrine therapy, biological targeted therapy, etc. Among these, chemotherapy is one of the commonly used methods for breast cancer treatment. 7 However, chemotherapy resistance is the main reason leading to the recurrence and metastasis of breast cancer patients. 8 The most commonly used agents in chemotherapy is doxorubicin. Due to the resistance of some breast cancer cells to doxorubicin, drug-resistant cells limit the use of doxorubicin. 9 Drug resistance can produce not only resistance to a chemotherapeutic agents but also crossresistance (namely multidrug resistance (MDR)) to multiple antitumor agents with different structures and mechanisms of action. 10 In recent years, significant progress has been made in the study of drug resistance. The mechanisms of drug resistance mainly include overexpression of drug resistance proteins such as multiple drug resistance protein (MDR1) and breast cancer resistance protein (BCRP), 11 the changes of some proteases in the cells leading to enhanced cell detoxification, such as overexpression of glutathione-s-transferase (GST) or increased activity, increased ability to repair DNA damage, increased anti-apoptotic ability, and changes in target molecules. However, the mechanism of tumor drug resistance is extremely complex, and the molecular signaling regulatory network caused by tumor drug resistance is still not fully elucidated. Constantly, exploring new mechanisms of tumor drug resistance to improve the efficacy of chemotherapy is one of the key issues to overcome cancer. Studies have shown that chemotherapy resistance is closely related to tumor metastasis. 12 For example, chemotherapy-resistant tumors are prone to distant metastases, and metastatic tumors have stronger chemoresistance. 13 This has aroused the wide interest of researchers. Exploring the intrinsic mechanism of drug resistance and metastasis can provide new research ideas for the reversal of tumor resistance and prevention of tumor metastasis during chemotherapy.
The Snail gene superfamily is a family of transcriptional repressors with a zinc finger structure. Snail (Snail1) and Slug (Snail2) are members of the Snail gene superfamily. They are able to bind to a regulatory element of the E-cadherin promoter region, thereby inhibiting E-cadherin expression at the transcriptional level. 14 Zhang et al. demonstrated that Snail can promote cell motility and vascular formation by regulating the activation of RhoA, which also reveals that Snail may play an important role in tumor growth and proliferation. 15 Tsubaki et al. found that the receptor activator of nuclear factor-B (RANK) can activate the NF-B pathway, thereby enhancing the expression of Snail and Twist, and subsequently causing the formation of EMT and migration, invasion and metastasis of tumor cell. 16 In addition, studies have found that comparing the corresponding normal tissue, the expression of E-cadherin in poorly differentiated malignant tumors can be lost completely or reduced, which is a common phenomenon in many human tumors. 17 Kremer et al. found that the growth of tumor cells with transfected wild-type E-cadherin was slower than that of control cells, and the expression of E-cadherin was completely lost in tumor metastases. 18 From the study of esophageal cancer, it was found that E-cadherin negative expression was more prone to hematogenous metastasis, especially liver and lung metastases. 19 Inhibition of signal molecules that regulate EMT, such as Snail, E-cadherin, and Slug, can increase the sensitivity of tumor cells to chemotherapy drugs. 20 Although little is known about the molecular mechanism of EMT mediated tumor resistance, there is no doubt that EMT is a common phenomenon in the development of drug resistance. Intervention with EMT can provide a new research strategy for reversing drug resistance in tumor and inhibiting tumor metastasis.
In this experiment, the mRNA and protein contents of Snail and E-cadherin in both adriamycin-resistant human breast cancer MCF-7/ADM cells and nonresistant MCF-7 cells were higher than those in normal breast cells. This further demonstrates that Snail expression is enhanced and E-cadherin expression is decreased in breast cancer cells. This study also showed that Snail protein and mRNA of adriamycinresistant human breast cancer MCF-7/ADM cells were significantly higher than those of normal breast cells and non-resistant MCF-7 cells, and the E-cadherin protein and mRNA of adriamycin-resistant human breast cancer MCF-7/ADM cells were significantly lower than those of normal breast cancer cells and non-drug resistant MCF-7 cells. This shows that Snail and E-cadherin may play a role in the regulation of drug resistance in breast cancer cells, which indicates a new direction for the targeted treatment of resistant breast cancer cells and it has important guiding significance for breast cancer treatment and prognosis evaluation.
CONCLUSION
In brief, adriamycin-resistant human breast cancer MCF-7/ADM cell strains have high expression of Snail and low expression of E-cadherin, which points out a new research direction for the targeted therapy of drug-resistant breast cancer cells, and provides clinical guidance for breast cancer therapy and prognosis evaluation. 
